OCGN - Ocugen - Stock Forecast

Healthcare - Sector
Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

OCGN is currently covered by 4 analysts with an average price target of $3. This is a potential upside of $2.23 (289.61%) from yesterday's end of day stock price of $0.77.

Ocugen's activity chart (see below) currently has 33 price targets and 42 ratings on display. The stock rating distribution of OCGN is 100% BUY.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 45.15% with an average time for these price targets to be met of 31 days.

Highest price target for OCGN is $7, Lowest price target is $5, average price target is $4.67.

Most recent stock forecast was given by SWAYAMPAKULA RAMAKANTH from HC WAINWRIGHT on 15-May-2024. First documented stock forecast 20-Jun-2018.

Currently out of the existing stock ratings of OCGN, 11 are a BUY (100%).

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Buy

$7

$5.99 (593.07%)

11 months 18 days ago
(15-May-2024)

2/7 (28.57%)

$5.04 (257.14%)

92

Buy

$5

$3.99 (395.05%)

$5

11 months 18 days ago
(15-May-2024)

0/7 (0%)

$3.04 (155.10%)

Buy

$2

$0.99 (98.02%)

$4.5

1 years 8 months 2 days ago
(31-Aug-2023)

0/2 (0%)

$1.57 (365.12%)

Buy

$3

$1.99 (197.03%)

2 years 2 months 2 days ago
(01-Mar-2023)

0/1 (0%)

$2 (200.00%)

Buy

$11

2 years 11 months 1 days ago
(02-Jun-2022)

3/3 (100%)

$1.81 (19.70%)

80

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What is OCGN (Ocugen) average time for price targets to be met?

On average it took 31 days on average for the stock forecasts to be realized with a an average price target met ratio 45.15

Which analyst has the current highest performing score on OCGN (Ocugen) with a proven track record?

SWAYAMPAKULA RAMAKANTH

Which analyst has the current lower performing score on OCGN (Ocugen) with a proven track record?

JENNIFER KIM

Which analyst has the most public recommendations on OCGN (Ocugen)?

Swayampakula Ramakanth has 13 price targets and 10 ratings on OCGN

Which analyst is the currently most bullish on OCGN (Ocugen)?

Keay Nakae with highest potential upside - $7.6

Which analyst is the currently most reserved on OCGN (Ocugen)?

Kristen Kluska with lowest potential downside - -$0

Ocugen in the News

Ocugen to Host Conference Call on Friday, May 9 at 8:30 A.M. ET to Discuss Business Updates and First Quarter 2025 Financial Results

MALVERN, Pa., May 02, 2025 (GLOBE NEWSWIRE) — Ocugen, Inc. (Ocugen or the Company) (NASDAQ: OCGN), a pioneering biotechnology leader in gene therapies for blindness diseases, today announced that it will host a conference call and live webcast to discuss the Company’s first quarter 2025 financial results and provide a business update at 8:30 a.m....

Ocugen to Present at the 2025 Cell & Gene Meeting on the Med

MALVERN, Pa., April 08, 2025 (GLOBE NEWSWIRE) — Ocugen, Inc. (Ocugen or the Company) (NASDAQ: OCGN), a pioneering biotechnology leader in gene therapies for blindness diseases, today announced that Dr. Shankar Musunuri, Chairman, Chief Executive Officer, and Co-founder of Ocugen will present at the 2025 Cell & Gene Meeting on the Mediterranean being held April...

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?